Sartorius Stedim Biotech S.A./ADR

Overview

Sartorius Stedim Biotech S.A./ADR is an American Depositary Receipt program that represents ownership in shares of Sartorius Stedim Biotech, a French-based subsidiary of the Sartorius Group. The group supplies lab instruments and bioprocess equipment, with manufacturing sites in Germany, France, Puerto Rico, and China, and sales concentrated in Europe, North America, and Asia. The ADR enables US investors to trade the underlying shares on over-the-counter markets in dollar terms, without independent management, investment discretion, or portfolio activity beyond the sponsor’s administrative functions.